MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation Finanzkreislauf 2011-2026 | DHR
Finanzkreislauf Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.5 | 83.5 | 93.5 | 79.1 | 72.3 | 65.9 | 70.3 | 72.2 | 85 | 79.7 | 72.1 | 64.9 | 66.1 | 76.3 | 85.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 93.5 | 64.9 | 76.3 |
Finanzkreislauf Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 | - | - | - | - | 76 | 67.6 | - | -12.8 | 26.6 | 65.5 | - | -7.61 | -6.79 | 29.5 | 59.8 | -4.84 | -4.96 | 33.5 | 55.5 | -6.66 | -8.3 | 37.4 | 63.2 | 86.2 | 83.3 | 84.5 | 63.4 | 81.5 | 79.5 | 82.3 | 63 | 96.7 | 74.8 | 72.1 | 60.2 | 66.9 | 65.1 | 66.8 | 61 | 67.7 | 66.7 | 74.8 | 59.9 | 78.9 | 76.6 | 80.5 | 59 | 77.1 | 95.6 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 96.7 | -12.8 | 56.2 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
275 | $ 2.85 | -3.72 % | $ 92.5 K |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
111 | $ 118.6 | 0.4 % | $ 36.1 B | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 13.82 | -2.68 % | $ 418 M | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
45.9 | $ 27.55 | -1.59 % | $ 765 M | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 175.77 | -1.61 % | $ 8.71 B | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 108.44 | 0.16 % | $ 8.94 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
103 | $ 635.29 | -0.22 % | $ 51.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 283.19 | -1.07 % | $ 23.6 B | USA |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 79.15 | 3.74 % | $ 5.34 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 315.61 | -0.56 % | $ 27.1 B |  Schweiz |
|
Biodesix
BDSX
|
41.7 | $ 15.5 | -1.59 % | $ 2.01 B | USA |
 |
Myriad Genetics
MYGN
|
49.3 | $ 5.26 | 4.89 % | $ 487 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 9.53 | 0.26 % | $ 1.22 B | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
National Research Corporation
NRC
|
33 | $ 13.37 | -3.47 % | $ 328 M | USA |
 |
Natera
NTRA
|
81.5 | $ 206.39 | 3.11 % | $ 20.3 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.12 | -1.78 % | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 208.28 | -0.95 % | $ 23.1 B | USA |
 |
Organovo Holdings
ONVO
|
-82.8 K | - | -2.3 % | $ 19.4 M | USA |
 |
OPKO Health
OPK
|
242 | $ 1.22 | -2.02 % | $ 847 M | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.51 | -7.1 % | $ 453 M | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | $ 103.38 | 0.02 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
208 | $ 8.8 | 0.34 % | $ 551 M | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 10.3 | -4.19 % | $ 292 M | Israel |
 |
DexCom
DXCM
|
134 | $ 73.0 | -1.06 % | $ 28.5 B | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
45.3 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-3.19 | $ 24.78 | 0.38 % | $ 32.2 M | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 24.01 | -4.59 % | $ 254 M | China |
 |
Illumina
ILMN
|
142 | $ 129.9 | -2.25 % | $ 20.7 B | USA |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |  Britain |
 |
VolitionRx Limited
VNRX
|
52.3 | $ 0.2 | -0.74 % | $ 19.2 M |  Singapore |